Treasury Yield Surge Challenges RiskFree Status Creates Potential for Intermediate BBB and HighYield Bonds Quiet Revolution MercedesBenz GClass EV and Jeep Grand Wagoneer Lead the 2026 SUV Market Shift Flowers Foods Reaffirms FullYear Guidance Amid Input Cost Pressures Natural Gas Futures Decline as Weather Forecasts Warm for Early February Ethereums Potential to Reclaim 2021 Highs Against Bitcoin Market Analysis AST SpaceMobile Gains as Market Approval Signals New Phase in Satellite Communications PRG Q1 2026 Earnings EPS Surges Past Estimates by 54 OKUR Q1 2026 Earnings WiderThanExpected Loss Reflects ClinicalStage Investment ZURA Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage First Mid Bancshares Inc FMBH Q1 2026 Earnings Strong EPS Beat Amid Quiet Market Reaction CPK Q1 2026 Earnings Earnings Beat Estimates as Utility Segment Drives Strong Results CASS Q1 2026 Earnings EPS Beats Estimates by Nearly 6 Banco De Chile ADS BCH Holds Steady Near 3755 as Support and Resistance Levels Tighten Heartbeam Inc Warrant BEATW Slumps 23 A Tight Trading Range at 007 Flutter Entertainment FLUT Edges Higher Near Resistance Can the Uptrend Continue National Research Corporation NRC Slips 053 Tests Key Support Zone Freightos CRGO Holds Near Support After Modest Decline Testing Key Levels SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms GSK Q1 2026 Earnings EPS Surprise Beats Estimates Stock Slips Slightly Westwater Resources WWR Dips 213 but Maintains Support at 053 Amid Graphite Sector Volatility YALA Q1 2026 Earnings EPS of 016 Highlights Solid Performance Amid Limited Disclosures OPCH Q1 2026 Earnings EPS Beats Estimates by 546 Amid Revenue Data Unavailability AMWD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Cost Discipline GEL Q1 2026 Earnings Significant EPS Miss Amid Challenging Conditions CALM Q1 2026 Earnings Earnings Per Share Surges 299 Above Estimates Stock Reacts Mildly FIS Q1 2026 Earnings EPS Beat Cushions the Blow as Stock Slips SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment